AI assistant
Sending…
DEXCOM INC — Director's Dealing 2013
Dec 13, 2013
30198_dirs_2013-12-13_37d6708c-3af4-4fe2-bf0e-38936f12fb29.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-12-12
Reporting Person: AUGUSTINOS NICHOLAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-12 | Common Stock | S | 11321.0 | $34.4046 | Disposed | 11130 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $34.40 to $34.435. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
F2: Included in this number are 11,130 unvested restricted stock units, which were granted on May 31, 2013 and shall vest through May 31, 2014.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17